PharmaCyte Biotech, Inc.
USD0.77
+0.04 (+5.34%)
CEO
Joshua N. Silverman
IPO Date
2013-01-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.74
Prev. Close
$0.73
Day Low
$0.72
Day High
$0.78
52W Low
$0.63
52W High
$1.51
Market Cap
$0.01B
Volume
0.16M
| 60.9 |
| 30 Apr 2023 | FY | 0.0% | 0.0% | -5.9% | -5.9% | 0.00 | 116.18 | -13.2 |
| 30 Apr 2022 | FY | 0.0% | 0.0% | -4.7% | -4.7% | 0.00 | 121.38 | -8.5 |
| 30 Apr 2021 | FY | 0.0% | 0.0% | -53.2% | -48.0% | 0.01 | 3.14 | -11.2 |
| 30 Apr 2020 | FY | 0.0% | 0.0% | -75.2% | -62.1% | 0.01 | 1.01 | -9.0 |
| 30 Apr 2019 | FY | 0.0% | 0.0% | -80.7% | -70.3% | 0.00 | 0.88 | -11.5 |
| 30 Apr 2018 | FY | 0.0% | 0.0% | -118.4% | -106.5% | 0.00 | 1.99 | -7.9 |
| 30 Apr 2017 | FY | 0.0% | 0.0% | -55.0% | -51.3% | 0.00 | 6.10 | -14.4 |
| 30 Apr 2016 | FY | 0.0% | 0.0% | -93.0% | -84.7% | 0.00 | 3.18 | -8.8 |
| -0.2 |
| 31 Jul 2025 | Q1 | 0.0% | 0.0% | -19.2% | -18.5% | 0.00 | 18.01 | -0.2 |
| 30 Apr 2025 | Q4 | 0.0% | 0.0% | 22.6% | 21.3% | 0.00 | 7.68 | 0.2 |
| 31 Jan 2025 | Q3 | 0.0% | 0.0% | -7.6% | -6.9% | 0.00 | 14.20 | -0.9 |
| 31 Oct 2024 | Q2 | 0.0% | 0.0% | -3.4% | -2.7% | 0.00 | 4.47 | -2.4 |
| 31 Jul 2024 | Q1 | 0.0% | 0.0% | 44.2% | 33.4% | 0.00 | 4.40 | 0.2 |
| 30 Apr 2024 | Q4 | 0.0% | 0.0% | 3.4% | 2.2% | 0.00 | 6.80 | 3.2 |
| 31 Jan 2024 | Q3 | 0.0% | 0.0% | -1.3% | -0.9% | 0.00 | 8.16 | -7.6 |
| 31 Oct 2023 | Q2 | 0.0% | 0.0% | 4.8% | 3.5% | 0.00 | 14.08 | 2.1 |